Immunology of the Infection Perinatal
EP38
1 other identifier
observational
93
0 countries
N/A
Brief Summary
ANRS-EP38-IMMIP is a non interventional study. A single blood sample (30 mL) was drawn during a hospital visit for clinical follow-up. Immunological assays were performed on fresh blood. Cells and plasma were stored and kept frozen for additional biological evaluations. Patients are included in the French perinatal cohort (ANRS CO-10), or have been followed since before 1996 in the same clinical sites as patients who belong to ANRS CO-10. In the ANRS CO-10 cohort, all patients are prospectively followed from birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2007
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 24, 2009
CompletedFirst Posted
Study publicly available on registry
January 26, 2010
CompletedNovember 18, 2010
November 1, 2010
2 years
December 24, 2009
November 17, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To describe the immune and virological status of perinatally infected patients that are above 15 yrs old and
Secondary Outcomes (1)
To study their associations with the current virological/clinical and therapeutic status, the duration of uncontrolled viremia (defined by treatment history), the virological, immunological (CD4+ numbers), and clinical status
Interventions
A single blood sample (30 mL) was drawn during a hospital visit for clinical follow-up. Immunological assays were performed on fresh blood. Cells and plasma were stored and kept frozen for additional biological evaluations
Eligibility Criteria
Patients are included in the French perinatal cohort (ANRS CO-10), or have been followed since before 1996 in the same clinical sites as patients who belong to ANRS CO-10. In the ANRS CO-10 cohort, all patients are prospectively followed from birth
You may qualify if:
- Being included in the ANRS CO-10 cohort, or being followed in the same sites as such patients since before 1996
- Being followed in the Paris area
- HIV-1 infected through the perinatal route, and not HIV-2 co-infected
- No therapeutic changes for at least 6 months; single molecule change without modification of viral load is tolerated.
- Informed consent signed by the patients and by their legal guardians for those younger than 18.
You may not qualify if:
- \- Not Being affiliated to the French national social security system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- French National Agency for Research on AIDS and Viral Hepatitislead
- Institut Pasteurcollaborator
- University of Paris 5 - Rene Descartescollaborator
- Hôpital Necker-Enfants Maladescollaborator
Related Publications (1)
Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.
PMID: 22427678DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Warszawski MD Josiane, Methodologist
INSERM U 822, Hôpital de Bicêtre, portes 10 à 15, 82 rue du Général Leclerc, 94276 Le Kremlin-Bicêtre Cedex warszaws@vjf.inserm.fr ; Tel : 01 45 21 22 86
- PRINCIPAL INVESTIGATOR
Blanche PHD Stéphane
Hopital Necker Enfants malades-Service immunologie hématologie pédiatrique -149 rue de Sèvres- 75015 PARIS 01 44 49 48 24
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
December 24, 2009
First Posted
January 26, 2010
Study Start
February 1, 2007
Primary Completion
February 1, 2009
Study Completion
February 1, 2009
Last Updated
November 18, 2010
Record last verified: 2010-11